Sunday, December 3, 2023
Scientists, including those at biotech company Loyal, are exploring drugs to extend the lives of pet dogs, addressing the inevitable heartbreak of their shorter lifespans. The U.S. Food and Drug Administration has acknowledged progress in Loyal's efforts. However, ethical concerns arise, questioning if extended lifespans would result in a commitment to providing quality lives for aging dogs and potential issues if dogs outlive their owners.
Critics suggest reforming breeding practices and improving access to veterinary care as alternatives. While longevity drugs are being explored, experts advise current measures for fostering healthier aging in dogs, such as maintaining a healthy weight, regular exercise, and mental stimulation. The goal is not immortality but enhancing the quality of dogs' lives.
For more information see Emily Anthes “Could Longevity Drugs for Dogs Extend Your Pet's Life?”, The New York Times, November 29, 2023.
Special thanks to Lewis Saret (Attorney, Washington, D.C.) for bringing this article to my attention.